Immune checkpoint inhibitors in patients with pretreated HodgkinÊs lymphoma: a Korean single-center, retrospective study
Joon-Young HUR; Sang-Eun YOON; Seok-Jin KIM; Won-Seog KIM.
Blood Research
; : 85-90, 2020.
Artículo | WPRIM | ID: wpr-830998
Documentos relacionados
Immune checkpoint inhibitors in patients with pretreated HodgkinÊs lymphoma: a Korean single-center, retrospective study.
[Mantle cell lymphoma: case report].
[Leukemization of follicular lymphoma: The features of diagnostic and clinical course of a rare form of the disease].
[Clinical features and prognosis of children with Burkitt's lymphoma: an analysis of 62 cases].
[Diagnosis and treatment of HIV-associated lymphoma: Update 202].
[High dose therapy with autologous stem cell transplantation in patients with Hodgkin's lymphoma: long-term follow-up in patients treated in one center].
[Efficacy and safety of rituximab in children and adolescents with mature B-cell non-Hodgkin's lymphoma: a Meta analysis].
[Primary non-Hodgkin orbital lymphoma: case report].
[Non-Hodgkin's lymphoma: clinical symptoms, therapy and prognosis in 37 patients].
[Primary cardiac lymphoma: a case report].